Cargando…
Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma
Because there are few studies regarding the clinical impact of circulating EBV-DNA in peripheral T-cell lymphomas (PTCLs), we tried to evaluate the role of EBV-DNA in whole blood as a prognostic factor for PTCL. We retrospectively reviewed 110 PTCL patients with median age of 63 (20-94) years. Forty...
Autores principales: | Kim, Yu Ri, Kim, Soo-Jeong, Cheong, June-Won, Chung, Haerim, Jang, Ji Eun, Kim, Yundeok, Yang, Woo-Ick, Min, Yoo Hong, Kim, Jin Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696183/ https://www.ncbi.nlm.nih.gov/pubmed/29190917 http://dx.doi.org/10.18632/oncotarget.21251 |
Ejemplares similares
-
Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin’s lymphoma
por: Kim, Yu Ri, et al.
Publicado: (2021) -
Impact of Epstein-Barr Virus on Peripheral T-Cell Lymphoma Not Otherwise Specified and Angioimmunoblastic T-Cell Lymphoma
por: Kim, Tong-Yoon, et al.
Publicado: (2022) -
Epstein-Barr virus-associated peripheral T-Cell lymphoma involving spleen in a renal transplant patient.
por: Lee, Hye Kyung, et al.
Publicado: (2003) -
Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study
por: Kim, Yu Ri, et al.
Publicado: (2022) -
Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
por: Park, Hyunsung, et al.
Publicado: (2017)